These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8228032)

  • 1. The rapid change to monotherapy with valproic acid in children.
    Hurst DL
    J Child Neurol; 1993 Oct; 8(4):357-9. PubMed ID: 8228032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
    Petrukhin AS; Mukhin KIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Pylaeva OA; Petrukhin AS; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):61-5. PubMed ID: 15554145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depakine in the therapy of epilepsy in children and adolescents].
    Guzeva VI; Fomina MIu; Korostovtsev DD; Guzeva VV; Guzeva OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):34-9. PubMed ID: 18379470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old].
    Motte J; Pedespan JM; Sevestre M; Chiron C;
    Arch Pediatr; 2005 Oct; 12(10):1533-9. PubMed ID: 16099147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy.
    Wheless JW; Neto W; Wang S;
    J Child Neurol; 2004 Feb; 19(2):135-41. PubMed ID: 15072107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate monotherapy in children.
    Murphy JV
    Am J Med; 1988 Jan; 84(1A):17-22. PubMed ID: 3146220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review.
    Sinclair DB; Berg M; Breault R
    J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover from polytherapy to monotherapy in primary generalized epilepsy.
    Mattson RH; Cramer JA
    Am J Med; 1988 Jan; 84(1A):23-8. PubMed ID: 3146221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of body mass index and plasma galanin in children with epilepsy following valproate sodium treatment].
    Wang KL; Shi RF; Tang HX
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):488-9. PubMed ID: 20540863
    [No Abstract]   [Full Text] [Related]  

  • 20. Is valproate monotherapy a practical possibility in chronically uncontrolled epilepsy?
    Armour DJ; Veitch GB
    J Clin Pharm Ther; 1988 Feb; 13(1):53-64. PubMed ID: 3129441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.